Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Wellgistics Health, Inc. Common Stock (WGRX)

Compare
3.6700
-0.1600
(-4.18%)
As of 9:30:00 AM EDT. Market Open.
Loading Chart for WGRX
  • Previous Close 3.8300
  • Open 3.6700
  • Bid 3.6700 x 100
  • Ask 4.1200 x 100
  • Day's Range 3.6700 - 3.6700
  • 52 Week Range 2.3200 - 5.6900
  • Volume 7,476
  • Avg. Volume 185,694
  • Market Cap (intraday) 190.636M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1500
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

www.wellgisticshealth.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: WGRX

View More

Performance Overview: WGRX

Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

WGRX
15.63%
S&P 500 (^GSPC)
7.82%

1-Year Return

WGRX
15.63%
S&P 500 (^GSPC)
7.12%

3-Year Return

WGRX
15.63%
S&P 500 (^GSPC)
23.43%

5-Year Return

WGRX
15.63%
S&P 500 (^GSPC)
94.80%

Compare To: WGRX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WGRX

View More

Valuation Measures

Annual
As of 4/14/2025
  • Market Cap

    198.95M

  • Enterprise Value

    223.03M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.98

  • Price/Book (mrq)

    29.54

  • Enterprise Value/Revenue

    12.30

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -37.82%

  • Return on Assets (ttm)

    -13.32%

  • Return on Equity (ttm)

    -357.65%

  • Revenue (ttm)

    18.13M

  • Net Income Avi to Common (ttm)

    -6.86M

  • Diluted EPS (ttm)

    -0.1500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.03M

  • Total Debt/Equity (mrq)

    371.21%

  • Levered Free Cash Flow (ttm)

    6.37M

Research Analysis: WGRX

View More

Company Insights: WGRX

Research Reports: WGRX

View More

People Also Watch